Bibliography
- Williams RJ. Discontinued drugs in 2006: oncology drugs. Expert Opin Investig Drugs 2008;17(3):269-83
- Williams RJ. Discontinued drugs in 2007: oncology drugs. Expert Opin Investig Drugs 2008;17(12):1791-816
- Walker I, Newell H. Do molecularly targeted agents in oncology have reduced attrition rates. Nat Rev Drug Discov 2009;8(1):15-6
- Available from: http://www.clinicaltrials.gov/ct2/show/NCT00147550? term=pd-0325901&rank=2
- Force T, Kerkelä R. Cardiotoxicity of the new cancer therapeutics – mechanisms of, and approaches to, the problem. Drug Discov Today 2008;13(17/18):778-84
- Scrip news. 2009 Feb 27th:6-7
- Cancer drug. 2009 Dec 17th:1
- Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 2004;3(8):711-5
- The Pharmaprojects database. In Informa, UK 2009